TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15888712

Group type: EXPERIMENTAL
Intervention: Double-bundle graft
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Single-bundle graft
Number of subjects: 8
Study: 12207074

Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI) administered intravenously at a dose of 150,000 U every 12 h from the start of surgery until postoperative day 5
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI)
Number of subjects: 16
Study: 9445284

Group type: EXPERIMENTAL
Intervention: Abdominal strapping
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no abdominal strapping)
Number of subjects: 8
Study: 7979808

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (3.6 mM)
Number of subjects: 30
Study: 3125794

Group type: EXPERIMENTAL
Intervention: 0.5% to 2% arachidonic acid applied under occlusion every 24 to 48 hours, five to seven times
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Histologic examination after treatment with arachidonic acid
Number of subjects: 45
Study: 4103277

Group type: EXPERIMENTAL
Intervention: 200 mug of anti-D gammaglobulin
Number of subjects: 844

Group type: EXPERIMENTAL
Intervention: Passive administration of anti-D gammaglobulin
Number of subjects: 844
Study: 30917125

Group type: EXPERIMENTAL
Intervention: PRS-080#22 (doses 0.08-16 mg/kg for healthy volunteers, 2-8 mg/kg for CKD patients)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: PRS-080#22
Number of subjects: 72
Study: 28262603

Group type: EXPERIMENTAL
Intervention: Paroxetine treatment for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Baseline measures of AA and CRP
Number of subjects: 70

Group type: COMPARATOR
Intervention: Baseline measures of amygdala-reactivity
Number of subjects: 70
Study: 26107444

Group type: EXPERIMENTAL
Intervention: Esophageal displacement using transesophageal echocardiography transducer
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Esophageal displacement
Number of subjects: 704

Group type: COMPARATOR
Intervention: No esophageal displacement (control)
Number of subjects: 704
Study: 22093070

Group type: EXPERIMENTAL
Intervention: Concentrate supplementation at 0.5% of BW
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Concentrate supplementation at 1% of BW
Number of subjects: 15

Group type: COMPARATOR
Intervention: Forage-only diet (Control)
Number of subjects: 15
Study: 21355098

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 58
Study: 18547460

Group type: EXPERIMENTAL
Intervention: Exposure to abstract artwork created by a member of an out-group university under baseline conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to abstract artwork created by a member of an out-group university following a manipulation of threat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated exposure to out-group-relevant attitude objects following a threat to identity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reported emotion as a mediator
Number of subjects: 0
Study: 16434132

Group type: EXPERIMENTAL
Intervention: Preoperative classification as 'difficult' on the Pederson scale
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: High Parant scores
Number of subjects: 105

Group type: COMPARATOR
Intervention: Pederson score
Number of subjects: 105
Study: 14758145

Group type: EXPERIMENTAL
Intervention: rPAF‐AH 1.0 mg/kg intravenously once daily for five consecutive days
Number of subjects: 1425

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1425
Study: 11726412

Group type: EXPERIMENTAL
Intervention: Remifentanil-based anesthetic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Halothane-based anesthetic
Number of subjects: 60
Study: 9253907

Group type: EXPERIMENTAL
Intervention: Oxandrolone + high-protein diet (2 g/kg/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: High-protein diet alone (2 g/kg/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Retrospective group (high-calorie, high-protein diet with 1.3 to 1.4 g/kg/day)
Number of subjects: 23
Study: 8441086

Group type: EXPERIMENTAL
Intervention: Soy-based formula (Prosobee)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Soy-based formula (Isomil)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cow-milk formula (Similac)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Human milk (HM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: All groups (HM, CBF, SBF)
Number of subjects: 72
Study: 3756982

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (1 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline (1 ml)
Number of subjects: 9
Study: 31888700

Group type: EXPERIMENTAL
Intervention: Maisha intervention (counseling and video session prior to HIV testing, plus two additional sessions for HIV-positive participants)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 1000
Study: 29862410

Group type: EXPERIMENTAL
Intervention: Tart cherry juice (480 ml daily for 12 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control drink (matched for energy and sugar content)
Number of subjects: 37
Study: 27412869

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (Orsiro)
Number of subjects: 2525

Group type: COMPARATOR
Intervention: Biolimus-eluting stent (Nobori)
Number of subjects: 2525
Study: 24718398

Group type: EXPERIMENTAL
Intervention: Enhanced care by community health workers
Number of subjects: 260

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 260
Study: 21882288

Group type: EXPERIMENTAL
Intervention: Combined treatment for depression (psychotherapy plus antidepressants)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard treatment (antidepressants alone)
Number of subjects: 28
Study: 19678776

Group type: EXPERIMENTAL
Intervention: Guided imagery (experimental group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (control group)
Number of subjects: 60
Study: 17475125

Group type: EXPERIMENTAL
Intervention: Vaginal birth
Number of subjects: 2078

Group type: COMPARATOR
Intervention: CS during active labour
Number of subjects: 2078

Group type: EXPERIMENTAL
Intervention: Short active phase of the second stage of labour (< 30 minutes)
Number of subjects: 2078
Study: 15183704

Group type: EXPERIMENTAL
Intervention: Virtual fluoroscopy for distal locking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Virtual fluoroscopy for guidewire placement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Virtual reality enhancement with 3-D cylinder model
Number of subjects: 0
Study: 11579009

Group type: EXPERIMENTAL
Intervention: Olanzapine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug-free comparison group
Number of subjects: 0
Study: 7854612

Group type: EXPERIMENTAL
Intervention: Spill residents
Number of subjects: 350

Group type: COMPARATOR
Intervention: Nonexposed controls
Number of subjects: 350
Study: 2638082

Group type: EXPERIMENTAL
Intervention: Power toothbrush with elliptical oscillating system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Power toothbrushes (various types)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 60

Group type: COMPARATOR
Intervention: Toothbrush alone
Number of subjects: 60
Study: 1235771

Group type: EXPERIMENTAL
Intervention: Secobarbital
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31326319

Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice a day for 12 weeks
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Nintedanib after placebo
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study: 27882439

Group type: EXPERIMENTAL
Intervention: MACS
Number of subjects: 237
Study: 25864416

Group type: EXPERIMENTAL
Intervention: KTP laser vaporization
Number of subjects: 229

Group type: COMPARATOR
Intervention: TURBT (transurethral electroresection)
Number of subjects: 229
Study: 23450428

Group type: EXPERIMENTAL
Intervention: Lokomat active orthosis in addition to individual exercises
Number of subjects: 52

Group type: COMPARATOR
Intervention: Individual exercises only (Control group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Lokomat active orthosis
Number of subjects: 52
Study: 21788316

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 95

Group type: COMPARATOR
Intervention: Local anesthesia with sedation
Number of subjects: 95
Study: 19090788

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy with atorvastatin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moderate lipid-lowering therapy with pravastatin
Number of subjects: 100
Study: 16720798

Group type: EXPERIMENTAL
Intervention: Concordant group (high perfusion correlate)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Discordant group (low perfusion correlate)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall dropouts
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall removals
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Completed participants
Number of subjects: 25
Study: 15531320

Group type: EXPERIMENTAL
Intervention: Conservative double flap (group 1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Extended double flap (group 2)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Single flap (group 3)
Number of subjects: 64

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 64
Study: 11033746

Group type: EXPERIMENTAL
Intervention: Preparation for Parenthood groups (psychosocial intervention)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Surviving Parenthood groups (for second‐time mothers)
Number of subjects: 187
Study: 9471604

Group type: EXPERIMENTAL
Intervention: Histidase measurement in blood
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Blood histidase indices
Number of subjects: 52
Study: 8170484

Group type: EXPERIMENTAL
Intervention: Deflazacort 2.0 mg/kg alternate-day therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 3046332

Group type: EXPERIMENTAL
Intervention: Cyclosporine (5 mg/kg/d)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no treatment initially)
Number of subjects: 8
Study: 29174792

Group type: EXPERIMENTAL
Intervention: Infliximab 5mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Infliximab 7.5mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 28319848

Group type: EXPERIMENTAL
Intervention: UC1010 (10 or 16mg) subcutaneously every second day during the luteal phase
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: UC1010
Number of subjects: 126
Study: 24695971

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 106

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 106
Study: 23726647

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 63

Group type: COMPARATOR
Intervention: friendly-TSST (control)
Number of subjects: 63
Study: 21569012

Group type: EXPERIMENTAL
Intervention: Child-focused intervention (n=71)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Context-focused intervention (n=57)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 128
Study: 18242572

Group type: EXPERIMENTAL
Intervention: Blocked execution of 1-key and 3-key responses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed execution of 1-key and 3-key responses
Number of subjects: 0
Study: 16504997

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg orally once daily for 3 days
Number of subjects: 35
Study: 12898459

Group type: EXPERIMENTAL
Intervention: Testosterone (T) alone (50 to 75 mg, intramuscular [IM])
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined Testosterone (T) and Growth Hormone (GH) treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Testosterone (T) treatment
Number of subjects: 10
Study: 10869628

Group type: EXPERIMENTAL
Intervention: Water-induced thermotherapy
Number of subjects: 27
Study: 9352700

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.2 mg fixed dose)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Terazosin (1-5 mg increasing doses)
Number of subjects: 98
Study: 7960688

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole once daily in the morning
Number of subjects: 203

Group type: COMPARATOR
Intervention: 300 mg ranitidine once daily at night
Number of subjects: 203
Study: 3506627

Group type: EXPERIMENTAL
Intervention: Mental stress test with high stimulus intensity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mental stress test with low stimulus intensity
Number of subjects: 0
Study: 31325124

Group type: EXPERIMENTAL
Intervention: Polarized polychromatic light (40 mW/cm2, wavelengths 480-3400 nm)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Continuous LED light (16 mW/cm2, wavelengths 625, 660, 850 nm)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pulsed LED light
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-therapeutic visible light (control)
Number of subjects: 36
Study: 29108938

Group type: EXPERIMENTAL
Intervention: Extrafine inhaled corticosteroids (QVAR 80 μg, two puffs twice per day, equivalent to 800 μg per day beclomethasone dipropionate)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 26711958

Group type: EXPERIMENTAL
Intervention: TRANSFoRm tools for recruitment and follow-up
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TRANSFoRm apps for reporting patient outcomes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Usability of TRANSFoRm tools
Number of subjects: 15
Study: 25202885

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 735
Study: 23431202

Group type: EXPERIMENTAL
Intervention: Manipulation of stimulus statistics
Number of subjects: 0
Study: 20456291

Group type: EXPERIMENTAL
Intervention: GHB (40 mg/kg or 60 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethanol (0.7 g/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1.25 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 18158634

Group type: EXPERIMENTAL
Intervention: Structured box model training curriculum
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 16647412

Group type: EXPERIMENTAL
Intervention: Plant stanols (2.0 g daily in low-fat yogurt)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (low-fat yogurt)
Number of subjects: 42
Study: 12732777

Group type: EXPERIMENTAL
Intervention: NovaSure (37 women)
Number of subjects: 67

Group type: COMPARATOR
Intervention: ThermaChoice (30 women)
Number of subjects: 67
Study: 10793592

Group type: EXPERIMENTAL
Intervention: MIKE (ketamine 3 mg kg‐1, midazolam 0.5 mg kg‐1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Midazolam (0.5 mg kg‐1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ketamine (6 mg kg‐1)
Number of subjects: 120
Study: 8616591

Group type: EXPERIMENTAL
Intervention: Alcohol (0.05 ml/kg to 1.0 ml/kg body weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1431767

Group type: EXPERIMENTAL
Intervention: Particles-in-tablet form of erythromycin (333 mg three times daily for 10 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythromycin ethylsuccinate (400 mg four times daily for 10 days)
Number of subjects: 0
Study: 3888133

Group type: EXPERIMENTAL
Intervention: Manual plus feedback group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Manual group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Feedback group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 29064340

Group type: EXPERIMENTAL
Intervention: Cerebellar tDCS (20 min, 2 mA) with right cathodal stimulation during verb generation task
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cerebellar tDCS (20 min, 2 mA) with sham stimulation during verb generation task
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cerebellar tDCS (20 min, 2 mA) with right cathodal stimulation during verb naming task
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cerebellar tDCS (20 min, 2 mA) with sham stimulation during verb naming task
Number of subjects: 12
Study: 27424011

Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 mg
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Liquefied ibuprofen 400 mg
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Comparison between Acetaminophen and Liquefied Ibuprofen
Number of subjects: 101
Study: 24408162

Group type: COMPARATOR
Intervention: Ponesimod 5, 10, or 20 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ponesimod 40 mg (up-titration schedule)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ponesimod (multiple doses)
Number of subjects: 10
Study: 22947225

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (500 mg DHA + 150 mg EPA, 400 μg 5-methyltetrahydrofolate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20827544

Group type: EXPERIMENTAL
Intervention: Operative treatment (cannulated screw fixation with postoperative splint immobilization for a maximum of 1 week)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conservative treatment (short arm cast until fracture union achieved)
Number of subjects: 94
Study: 17960642

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 141
Study: 15685078

Group type: EXPERIMENTAL
Intervention: Lower body positive pressure exercise at 60% body weight
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lower body positive pressure exercise at 20% body weight
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lower body positive pressure ambulation after anterior cruciate ligament reconstruction
Number of subjects: 15
Study: 14586246

Group type: EXPERIMENTAL
Intervention: Interferon alone
Number of subjects: 1251

Group type: EXPERIMENTAL
Intervention: Interferon + ribavirine
Number of subjects: 1251

Group type: EXPERIMENTAL
Intervention: Combined therapy after unsuccessful monotherapy
Number of subjects: 1251
Study: 10230589

Group type: EXPERIMENTAL
Intervention: Heidelberg Retina Flowmeter (HRF) measurements at the papilla with a frame size of 50 x 50 pixels
Number of subjects: 150
Study: 8723847

Group type: EXPERIMENTAL
Intervention: Laryngeal mask insertion with laryngoscope
Number of subjects: 48

Group type: COMPARATOR
Intervention: Blind laryngeal mask insertion
Number of subjects: 48
Study: 2068939

Group type: EXPERIMENTAL
Intervention: Auditory brainstem responses (ABRs) test for endolymphatic hydrops
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glycerol dehydration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo and two different drugs
Number of subjects: 30
Study: 6820890

Group type: EXPERIMENTAL
Intervention: Levamisole + Mitomycin C + Tegafur
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control (Mitomycin C + Tegafur)
Number of subjects: 155
Study: 31322037

Group type: EXPERIMENTAL
Intervention: Greater perceived friend social support
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Greater perceived familial social support
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Greater social support from both friends and family
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Greater AA/NA participation
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 489
Study: 29171821

Group type: EXPERIMENTAL
Intervention: 70 mg erenumab
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: 140 mg erenumab
Number of subjects: 955

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955
Study: 27134522

Group type: EXPERIMENTAL
Intervention: Iohexol-380
Number of subjects: 225

Group type: COMPARATOR
Intervention: Iohexol-350
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 225
Study: 25491514

Group type: EXPERIMENTAL
Intervention: Dental health education by qualified dentists and school teachers with supply of oral hygiene aids
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dental health education by qualified dentists and school teachers without supply of oral hygiene aids
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 15
Study: 22316412

Group type: EXPERIMENTAL
Intervention: HPV‐specific education with a mailed reminder
Number of subjects: 256

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 256
Study: 19224307

Group type: EXPERIMENTAL
Intervention: Two-incision approach
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mini-posterior approach
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mini-anterolateral approach
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aggressive postoperative rehabilitation program
Number of subjects: 24
Study: 17469045

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg) for two weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 15094147

Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric contractions (MVC)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sub-maximal voluntary isometric contractions (sub-MVC)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sub-MVC
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MVC
Number of subjects: 11
Study: 12575338

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amilodipine
Number of subjects: 60
Study: 9794673

Group type: EXPERIMENTAL
Intervention: 200 mg of mifepristone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 50 mg of mifepristone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 7641744

Group type: EXPERIMENTAL
Intervention: CO2 laser ablation
Number of subjects: 642

Group type: COMPARATOR
Intervention: LETZ
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: HPV positive
Number of subjects: 642

Group type: COMPARATOR
Intervention: No HPV infection
Number of subjects: 642